Literature DB >> 217531

Role of superoxide dismutase in cancer: a review.

L W Oberley, G R Buettner.   

Abstract

Diminished amounts of manganese-containing superoxide dismutase have been found in all the tumors examined to date. Lowered amounts of the copper-zinc-containing superoxide dismutase have been found in many, but not all, tumors. At the same time, tumors have been shown to produce superoxide radicals. It is shown how diminished enzyme activities along with radical production may lead to many of the observed properties of cancer cells. The apparent exploitation of the differences between normal and cancer cell superoxide dismutase activity in the treatment of cancer is discussed.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 217531

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  214 in total

Review 1.  Manganese superoxide dismutase: beyond life and death.

Authors:  Aaron K Holley; Sanjit Kumar Dhar; Yong Xu; Daret K St Clair
Journal:  Amino Acids       Date:  2010-05-08       Impact factor: 3.520

Review 2.  Manipulation of cellular redox parameters for improving therapeutic responses in B-cell lymphoma and multiple myeloma.

Authors:  Apollina Goel; Douglas R Spitz; George J Weiner
Journal:  J Cell Biochem       Date:  2012-02       Impact factor: 4.429

3.  Manganese superoxide dismutase is a p53-regulated gene that switches cancers between early and advanced stages.

Authors:  Sanjit K Dhar; Jitbanjong Tangpong; Luksana Chaiswing; Terry D Oberley; Daret K St Clair
Journal:  Cancer Res       Date:  2011-10-18       Impact factor: 12.701

Review 4.  An epigenetic perspective on the free radical theory of development.

Authors:  Michael J Hitchler; Frederick E Domann
Journal:  Free Radic Biol Med       Date:  2007-07-10       Impact factor: 7.376

5.  Proteomic analysis of cervical cancer cells treated with suberonylanilide hydroxamic acid.

Authors:  Jianxiong He; Canhua Huang; Aiping Tong; Bin Chen; Zhi Zeng; Peng Zhang; Chunting Wang; Yuquan Wei
Journal:  J Biosci       Date:  2008-12       Impact factor: 1.826

6.  Superior therapeutic index of calmangafodipir in comparison to mangafodipir as a chemotherapy adjunct.

Authors:  Jan Olof G Karlsson; Tino Kurz; Susanne Flechsig; Jacques Näsström; Rolf Gg Andersson
Journal:  Transl Oncol       Date:  2012-12-01       Impact factor: 4.243

7.  Mutations in the SOD2 promoter reveal a molecular basis for an activating protein 2-dependent dysregulation of manganese superoxide dismutase expression in cancer cells.

Authors:  Yong Xu; Fang Fang; Sanjit K Dhar; Antonio Bosch; William H St Clair; Edward J Kasarskis; Daret K St Clair
Journal:  Mol Cancer Res       Date:  2008-12       Impact factor: 5.852

8.  Response of multicellular tumor spheroids to liposomes containing TNF-alpha.

Authors:  F Weber; C Kremer; M Klinkhammer; B Rasier; M Brock
Journal:  J Neurooncol       Date:  1994       Impact factor: 4.130

Review 9.  Redox-modulated phenomena and radiation therapy: the central role of superoxide dismutases.

Authors:  Aaron K Holley; Lu Miao; Daret K St Clair; William H St Clair
Journal:  Antioxid Redox Signal       Date:  2014-02-14       Impact factor: 8.401

10.  Tissue-specific developmental regulation of superoxide dismutase (SOD-1 and SOD-2) activities in genetic strains of mice.

Authors:  N J Schisler; S M Singh
Journal:  Biochem Genet       Date:  1985-04       Impact factor: 1.890

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.